Recurrence of primary cutaneous CD30-positive lymphoproliferative disorder following COVID-19 vaccination

Caitlin M. Brumfiel, Meera H. Patel, David J. DiCaudo, Allison C. Rosenthal, Mark R. Pittelkow, Aaron R. Mangold

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
JournalLeukemia and Lymphoma
DOIs
StateAccepted/In press - 2021

Keywords

  • CD30-positive lymphoproliferative disorder
  • COVID-19 vaccination
  • COVID-19 vaccine
  • Lymphoma
  • lymphoproliferative disorder
  • mRNA vaccine

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this